ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
17.0185
0.27%
Brent Oil
82.765
0.00%
Bitcoin
63,827.60
-0.10%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Akoya BioSciences Inc (AKYA)

  7. Akoya BioSciences Inc (AKYA) Noticias

AKYA Akoya BioSciences Inc

4.04
0.05 (1.25%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Akoya BioSciences Inc AKYA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.05 1.25% 4.04 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.02 3.92 4.2288 4.04 3.99
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:00GLOBEAkoya Biosciences and Shanghai KR Pharmtech Announce Chinese..
22/4/202415:05GLOBEAkoya to Report First Quarter 2024 Financial Results on May..
05/4/202407:00GLOBEAkoya Biosciences Showcases Spatial Biology 2.0 Solutions at..
04/3/202416:18EDGAR2Form 8-K - Current report
04/3/202415:05GLOBEAkoya Reports Record Revenue in the Fourth Quarter of 2023..
04/3/202405:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
01/3/202420:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202408:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:05GLOBEAkoya to Report Fourth Quarter and Full Year 2023 Financial..
18/1/202407:00GLOBEAkoya Biosciences’ Technology Enables Queensland Spatial..
10/1/202415:02EDGAR2Form 8-K - Current report
10/1/202407:00GLOBEAkoya Biosciences Announces that Garry Nolan, Ph.D., James..
08/1/202414:57DJNAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher..
08/1/202405:02EDGAR2Form 8-K - Current report
07/1/202407:00GLOBEAkoya Biosciences Deploys the MaxFuse Algorithm Co-Developed..
03/1/202407:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/12/202318:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202307:05GLOBEAkoya to Participate at 42nd Annual J.P. Morgan Healthcare..
19/12/202315:23EDGAR2Form 144 - Report of proposed sale of securities
14/12/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202317:33EDGAR2Form 144 - Report of proposed sale of securities
27/11/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:37EDGAR2Form 144 - Report of proposed sale of securities
08/11/202315:06EDGAR2Form 8-K - Current report
08/11/202315:00GLOBEAkoya Reports Record Revenue in the Third Quarter of 2023..
02/11/202307:00GLOBEAkoya to Participate at Three Upcoming Investor Conferences
31/10/202308:00GLOBEAkoya Biosciences to Showcase New Spatial Biology 2.0..
17/10/202309:22GLOBEAkoya Biosciences Announces Peer-Reviewed Publication Using..
11/10/202315:05GLOBEAkoya to Report Third Quarter 2023 Financial Results on..
19/9/202307:00GLOBEAkoya Biosciences Sets a New Standard for Scaling Spatial..
06/9/202315:01EDGAR2Form 8-K - Current report
07/8/202315:10EDGAR2Form 8-K - Current report
07/8/202315:05GLOBEAkoya Reports Record Revenue in the Second Quarter of 2023..
07/8/202307:05GLOBEAkoya Biosciences Announces Milestone of 1,000 Peer-Reviewed..
26/7/202315:05GLOBEAkoya to Participate at Three Upcoming Investor Conferences
13/7/202316:10EDGAR2Form 144 - Report of proposed sale of securities
12/7/202317:28EDGAR2Form 144 - Report of proposed sale of securities
12/7/202307:05GLOBEAkoya to Report Second Quarter 2023 Financial Results on..
05/7/202315:05EDGAR2Form 8-K - Current report
28/6/202316:18EDGAR2Form 8-K - Current report
12/6/202315:05GLOBEAkoya to Participate at Two Upcoming Investor Conferences
07/6/202323:55GLOBEAkoya Biosciences Announces Pricing of Public Offering of..
07/6/202319:08DJNAkoya Biosciences Shares Fall on Executive Exits, Stock..
07/6/202315:08GLOBEAkoya Biosciences Announces Public Offering of Common Stock
08/5/202315:05GLOBEAkoya Reports Record Revenue in the First Quarter of 2023..

Su Consulta Reciente

NASDAQ
AKYA
Akoya BioSciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados